GlaxoSmithKline Consumer expands Horlicks portfolio

NEW DELHI: GlaxoSmithKline Consumer Healthcare today expanded its 'Horlicks' portfolio with the launch of a new flavour.

Horlicks Kesar Badaam is the fourth variant in the Horlicks portfolio; the other flavours available are Malt, Chocolate and Elaichi, GlaxoSmithKline Consumer Healthcare said in a statement.

"This latest product entry into the portfolio marks our expansion to newer sub categories offering specialised taste and value proposition to the consumers," GlaxoSmithKline Consumer Healthcare India EVP-Marketing Jayant Singh said.

The new variant, which has been launched in two packs; 400g refill for Rs 220 and 400g jar for Rs 225, will be sold through traditional and modern retail outlets across the country, the company said.

GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK, a global science based healthcare company.